Clinical Trials Logo

Hearing Loss, Noise-Induced clinical trials

View clinical trials related to Hearing Loss, Noise-Induced.

Filter by:

NCT ID: NCT04766853 Recruiting - Meniere Disease Clinical Trials

Verification of the Efficacy/Safety of the Intratympanic Drug Delivery for Hearing Loss

Start date: July 22, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This study is a prospective, randomized pilot study. To verify an efficacy and safety of the Intratympanic drug delivery vehicle, patients who have not responded to the existing standard treatment will be enrolled. Hearing test, endoscopy of tympanic membrane and CT scans will be conducted after intratympanic treatment for evaluation.

NCT ID: NCT04629664 Completed - Clinical trials for Hearing Loss, Sensorineural

FX-322 in Adults With Severe Sensorineural Hearing Loss

Start date: November 2, 2020
Phase: Phase 1
Study type: Interventional

This is a Phase 1b, prospective, randomized, double-blind, placebo-controlled, single-dose, multicenter, safety study of FX-322, administered by intratympanic injection, in adults with severe sensorineural hearing loss.

NCT ID: NCT04601909 Completed - Clinical trials for Hearing Loss, Sensorineural

FX-322 in Adults With Age-Related Sensorineural Hearing Loss

Start date: September 17, 2020
Phase: Phase 1
Study type: Interventional

This is a Phase 1b, prospective, randomized, double-blind, placebo-controlled, single-dose, multicenter, safety study of FX-322, administered by intratympanic injection, in adults with age-related sensorineural hearing loss.

NCT ID: NCT04482998 Not yet recruiting - Clinical trials for Acute Acoustic Trauma

Efficacy of Various Treatments for Acute Acoustic Trauma.

Start date: September 1, 2020
Phase:
Study type: Observational

Acute acoustic trauma is a growing concern in the IDF. there is currently no accepted treatment. The present retrospective study is intended to evaluate the efficacy of different treatment modalities in the IDF between 01/01/2010 and 15/06/2020.

NCT ID: NCT04183361 Enrolling by invitation - Clinical trials for Sensorineural Hearing Loss

ABR Characteristics and Salivary Cortisone Concentration in Noise-exposed Workers

Start date: November 1, 2019
Phase:
Study type: Observational

The aim of the research: Investigate the association of auditory evoked brainstem response characteristics with salivary cortisone concentrations in noise-exposed workers. Purpose of the research: 1. Investigate the magnitude of the amplitudes and latencies of auditory brainstem responses. 2. Investigate the concentration of cortisone in saliva. 3. To investigate the correlation of the characteristics of auditory evoked brainstem potentials with the age of the subjects or the length of work in noise. 4. Investigate the association of salivary cortisone concentration with subjects' age or length of work in noise. 5. Investigate the prevalence of mild, moderate and severe hearing impairment in the 19-35 age group. 6. Investigate the relationship of hearing threshold shift with the age of the subjects or the length of work in noise. 7. To investigate the difference in the characteristics of auditory evoked brainstem potentials and the difference in salivary cortisone concentration between subjects with a bilaterally normal hearing threshold (≤25 dB) at high frequencies and subjects with unilaterally or bilaterally increased hearing threshold (> 25 dB) at high frequencies . 8. Investigate the perceived stress and psychosocial risk factors in the workplace and their relationship to salivary cortisone concentrations. Research Hypothesis: There is an association between the characteristics of auditory evoked brainstem response and salivary cortisone concentrations in noise-exposed workers. Research participants Inclusion criteria: 1. male and female 2. ages 19-35 3. exposure to noise level ≥ 85 dB (A) per week at the workplace 4. work in noise from 1 to 16 years 5. workplace not involving exposure to carbon disulfide or a mixture of organic solvents that have toxic effects on the ear (toluene, xylene and styrene) 6. unilaterally or bilaterally normal otoscopic findings 7. unilaterally or bilaterally tympanogram: peak pressure value ± 50 daPa at 226 Hz with eardrum mobility of 0.3 to 1.3 mL Exclusion criteria: 1. information about an earlier sudden hearing loss 2. information on chronic middle ear inflammation 3. information on ear surgery (except placement of ventilation tubes in the eardrum) 4. information on dizziness associated with hearing loss and noise 5. information on insomnia 6. current use of oral corticosteroids 7. bilaterally found air-bone gap greater than 15 dB

NCT ID: NCT04172766 Recruiting - Hearing Loss Clinical Trials

Apple Hearing Study

Start date: November 14, 2019
Phase: N/A
Study type: Interventional

The Apple Hearing Study is a partnership between the University of Michigan and Apple to study sound exposure and its impact on hearing health. This groundbreaking study will advance the understanding of how hearing could be impacted over time by exposure to sound at certain levels. The investigators will measure headphone and environmental sound exposures over time among participants, and determine how these exposures impact hearing and stress levels. US residents who own an iPhone, download the Apple Research app and consent to participate will be randomly assigned to two groups, one with a "Basic" user interface in the Research app, and one with an "Advanced" user interface. Users in the "Advanced" group will receive additional information about their exposures and be given additional surveys and hearing tests based on their music and environmental sound exposures. The study will provide investigators with a better understanding of listening behavior and its overall impact on hearing health. This information will in turn help guide public health policy and prevention programs designed to protect and promote hearing health in the US and globally.

NCT ID: NCT04120116 Completed - Clinical trials for Sensorineural Hearing Loss

FX-322 in Adults With Stable Sensorineural Hearing Loss

Start date: October 4, 2019
Phase: Phase 2
Study type: Interventional

This is a phase 2a single and repeat dose exploratory efficacy study of intratympanic FX-322 compared to placebo in healthy male and female adults with stable sensorineural hearing loss.

NCT ID: NCT03878875 Completed - Clinical trials for Hearing Loss, Noise-Induced

Does Sound Conditioning Protect Against Temporary Hearing Damage

Start date: January 1, 2020
Phase:
Study type: Observational

This research project will contribute to the research surrounding the effect on the ear after noise exposure. This ever-growing field of research has never been more applicable than now with the increase of recreational noise exposure. Noise is the leading cause of preventable hearing loss and excessive occupational noise along with recreational noise exposure can cause a devastating disability. The World Health Organisation (WHO) estimates 1.1 billion young people could be at risk of hearing loss due to unsafe listening practices. One of the mechanisms that could increase the resistance against noise induced hearing loss is 'sound conditioning'. Animal studies have found that prior exposure to low level noise over a period of a few weeks can 'condition' the ear. This conditioning then reduces the susceptibility to high level exposure i.e. strengthening the ear. In this study, the investigators aim to determine whether previous exposure to loud noise can condition the human ear, reducing the temporary hearing loss and temporary tinnitus ("ringing in the ear") that sometimes occurs after attending a loud nightclub or live music event. There are many implications of this research. For one it will allow us to understand more about the susceptibility to exposure of sounds and the resistance against noise induced hearing loss. This will mean that the investigators can enable appropriate interventions if necessary. For example, individuals who are more susceptible due to low prior exposure may be advised that they are at risk, and encouraged to use hearing protection. Being able to learn more about the impacts of noise with hearing and educate others such as understanding the impacts from high-level exposure.

NCT ID: NCT03834714 Completed - Clinical trials for Hearing Loss, Noise-Induced

Noise Exposure and Near-Infrared Light

Start date: February 18, 2020
Phase: N/A
Study type: Interventional

The primary objective of this work is to determine the effect noise has on the auditory system (both auditory health and performance) and also the degree to which the effect of pre-noise therapy such as Near Infrared (NIR) light can mitigate the effects of noise exposure.

NCT ID: NCT03314116 Recruiting - Clinical trials for Hearing Loss, Noise-Induced

Risk Factors for Hearing Loss as a Result of Exposure to Noise During Military Training in the IDF

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

As part of the proposed work, the investigators would like to examine whether there is a need to use a training video to train IDF combat soldiers to improve the use of ear plugs and to prevent hearing loss from exposure to noise, and to characterize the hearing impaired epidemiology of recruits and the basic rate of hearing loss During basic training.